ALB and chronic kidney disease: In 2021, Imafuku et al. conducted a retrospective case-control study with a two-year follow-up, demonstrating that patients with Cys-albumin (equivalent to oxidized albumin) above the cutoff value (25.69%) showed significantly faster progression from CKD stage G2 to G3a compared to those below the cutoff [17].